Tag: LINC 2021

Real-world data on SeQuent Please OTW DCB presented at LINC 2021

One-year findings of the CONSEQUENT all-comers observational study of the paclitaxel drug-coated balloon (DCB) SeQuent Please OTW (B Braun) were reported at LINC 2021...
Luminor

Positive Luminor DCB data from EffPac and TINTIN trials presented at...

New clinical evidence for the use of the Luminor drug-coated balloon (DCB; Luminor) in complex lesions with long-term follow-up has been presented on the...

LINC 2021: Novel approaches and new data for BTK interventions revealed

In a late-breaking trial session at LINC 2021 (The Leipzig Interventional Course, 25–29 January, online), key updates on below-the-knee (BTK) interventions were in the...

LINC 2021: Long-term data show sustained efficacy and safety of paclitaxel...

A key theme among the late-breaking trial data presented at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) was the emergence of long-term...

LINC 2021 first time data releases in arteriovenous access: Positive results...

New data presented for the first time at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) are positive for the IN.PACT AV drug-coated...
MedAlliance SELUTION SLR

LINC 2021: 12-month BTK data with MedAlliance’s SELUTION SLR presented as...

Twelve-month results from the PRESTIGE below-the-knee (BTK) study have been presented as a late-breaking trial at LINC 2021 (25–29 January, virtual). The objective of...

Three studies evaluating Flex Vessel Prep system presented during LINC 2021

  VentureMed Group announced today that data from three studies evaluating the use of its Flex Vessel Prep (VP) system were presented during LINC 2021...

LINC 2021: Head-to-head trials take centre stage in drug-eluting technology late-breaking...

Data from two head-to-head trials on drug-eluting technologies in femoral artery treatment were presented during a late-breaking session at LINC 2021 (Leipzig Interventional Course;...

Five-year ILLUMENATE results confirm safety profile of Philips Stellarex DCB

Royal Philips has announced the final, five-year results of two randomised controlled trials (RCTs) that show no difference in all-cause mortality between patients treated...